Shanxi Panlong Pharmaceutical Group Limited By Share Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Shaanxi Panlong Pharmaceutical Group Co., Ltd. (abbreviated as Panlong Pharmaceutical; stock code: 002864) was established in 1997. It is a modern high-tech enterprise that integrates GAP planting of medicinal materials, drug production, research and development, sales, and pharmaceutical logistics as its core industries. The company has four wholly-owned subsidiaries, including Shaanxi Panlong Pharmaceutical Co., Ltd., Shaanxi Shangluo Panlong Plant Pharmaceutical Co., Ltd., and Panlong Pharmaceutical Health Products Co., Ltd Panlong Health Industry Holding Co., Ltd., two holding subsidiaries Shaanxi Bohua Pharmaceutical Co., Ltd. and Shaanxi Panlong Yunkang Network Technology Co., Ltd., as well as one non enterprise unit Shaanxi Panlong Pharmaceutical Research Institute. In 2016, it entered the "Top 100 Enterprises in Shaanxi" and was listed on the A-share market of the Shenzhen Stock Exchange in November 2017. From 2018 to 2021, it has been listed as one of the top 100 pharmaceutical companies in China four times. The company's production base is located in the Zhashui Panlong Ecological Industrial Park at the southern foot of the Qinling Mountains, known as the "natural medicine treasure trove". The management headquarters, pharmaceutical logistics, and drug research and development, distribution center are built in the Modern Textile Industrial Park in the Bahe New Area of Xi'an. At present, we have 19 production lines and supporting inspection and research equipment for tablets, capsules, and other products that have passed the new national GMP certification. We have a strong product lineup of over 100 specifications in 15 dosage forms and 12 functional categories, and have formed a production and operation scale with an annual output value of over 1 billion yuan. Our product marketing network covers the whole country, and we are deeply trusted and praised by doctors, experts, and patients. In 2018, the company established the Panlong Pharmaceutical Research Institute, Tightly focusing on the development strategy of "one body, two wings" ("one body" is to strengthen the pharmaceutical industry, including pharmaceuticals, health products, health products, as well as traditional Chinese medicine decoction pieces and formula granules; "left wing" is to focus on pharmaceutical commerce and cultural construction, develop drug distribution, build Wangjiacheng Pharmacy, and enhance brand influence through soft power; "right wing" Positioning the big health industry, utilizing the location advantage of Zhashui to focus on medical treatment, medical care, and medical aesthetics, with promoting the development of "Qin medicine" as its own responsibility, adhering to the research and development concept of "grasping the forefront and combining innovation and imitation", focusing on the main business, refining internal skills, and strengthening innovation with the focus of "specialization, precision, specialty, and novelty", and establishing strategic cooperative relationships with Xi'an Jiaotong University, Shaanxi Normal University, Northwest University, and other universities, Carry out industry university research cooperation and talent joint training. In recent years, the company has been successively recognized as a national enterprise technology center by the National Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the General Administration of Customs, and the State Administration of Taxation. It has also been recognized by the Shaanxi Provincial Department of Industry and Information Technology as a specialized, refined, and innovative small and medium-sized enterprise in Shaanxi Province, a research center for the engineering technology of traditional Chinese medicine preparations for rheumatism and tumors in Shaanxi Province, and a platform for the development and application of classic formulas in Shaanxi Province; Recognized as a postdoctoral innovation base by the Shaanxi Provincial Department of Human Resources and Social Security; Multiple times, it has been awarded the titles of Shaanxi Provincial Technology Innovation Demonstration Enterprise, Shaanxi Provincial Quality Benchmark, Shaanxi Provincial Intellectual Property Advantage Enterprise, etc. by the Provincial Department of Industry and Information Technology, Shaanxi Provincial Department of Science and Technology, and Shaanxi Provincial Intellectual Property Bureau. The company is in a leading position in China in tablet preparation process technology, Chinese medicine extraction and refining process technology, Chinese medicine drying process technology, Chinese medicine fingerprint application technology, Chinese medicine ultra-low temperature comminution technology, Chinese medicine traceability system technology, and traditional Chinese patent medicines and simple preparations secondary development technology based on multi-dimensional strategy. The company's production, inspection, research and development equipment and related technologies are at a leading level in the industry. Since its establishment, the company has adhered to the socialist core values as the leadership, and for many years has always adhered to nurturing society with a high sense of social responsibility and historical mission, actively practicing public welfare, and fulfilling social responsibilities. In 2000, the company proposed the "Double Hundred" talent plan to support 100 impoverished college students to complete their university studies; In the national poverty alleviation campaign, Chairman Xie Xiaolin led enterprises to drive more than 7520 impoverished individuals, opening up stable channels for their income growth, creating conditions for achieving the goal of sustainable poverty alleviation and prosperity, and achieving a "win-win" situation for farmers and enterprises. The company has been awarded the titles of "National Poverty Alleviation Leading Enterprise" by the National Poverty Alleviation Office, "Advanced Private Enterprise of" Ten Thousand Enterprises Helping Ten Thousand Villages "by the National Poverty Alleviation Office," National Contract and Credit Keeping Unit "by the State Administration for Industry and Commerce," Excellent Private Enterprise of Shaanxi Province "by the Shaanxi Provincial Party Committee and Government," Advanced Collective of Shaanxi Province "," May Day Labor Award "," Excellent Private Enterprise ", etc., and" Honest Enterprise of Shaanxi Province "by relevant provincial departments The "Leading Enterprise in Agricultural Industrialization in Shaanxi Province", "Innovative Enterprise in Shaanxi Province", "High tech Enterprise", "Science and Technology Demonstration Enterprise", "Model Taxpayer", etc. have won over 100 awards and have been commended and rewarded multiple times.Panlong Pharmaceutical will continue to adhere to the corporate purpose of "establishing the Panlong brand and caring for human health", adhere to the innovation and development as the center, and take customers' health needs as the guide, further establish and improve the Panlong health industry ecosystem, strengthen the main body of the pharmaceutical industry, expand the pharmaceutical commercial logistics, do a good job in traditional Chinese medicine health care and medical services, and strive to become an enterprise with core competitive advantages in the field of traditional Chinese patent medicines and simple preparations, serve the people, and make contributions to healthy China. |
| Headquarter | Shangluo City |
| Establish Date | 9/22/1997 |
| Listed Code | 002864.SZ |
| Listed Date | 11/16/2017 |
| Chairman | Xie Xiaolin. |
| CEO | Xie Xiaolin. |
| Website | www.pljt.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
